BolotinDPetronic-RosicV.
Dermatitis herpetiformis. Part II. Diagnosis, management, and prognosis. J Am Acad Dermatol. 2011;64(6):1027-1033.
2.
LuckyAWMaloneyJMRobertsJ. Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment. J Drugs Dermatol. 2007;6(10):981-987.
3.
DraelosZDCarterEMaloneyJM. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol. 2007;56(3):439.e431-410.
4.
WebsterGF. Is topical dapsone safe in glucose-6-phosphate dehydrogenase-deficient and sulfonamide-allergic patients?J Drugs Dermatol. 2010;9(5):532-536.
5.
SwartzentruberGSYantaJHPizonAF. Methemoglobinemia as a complication of topical dapsone. N Engl J Med. 2015;372(5):491-492.
6.
HandlerMZChaconAHShimanMISchachnerLA. Letter to the editor: application of dapsone 5% gel in a patient with dermatitis herpetiformis. J Dermatol Case Rep. 2012;6(4):132-133.
